Does regular treatment with ketotifen inhibit bronchoconstriction induced by isocapnic hyperventilation?
Open Access
- 26 July 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 24 (1) , 100-102
- https://doi.org/10.1111/j.1365-2125.1987.tb03143.x
Abstract
Eight asthmatic patients completed a 12‐week, double‐blind, placebo controlled study to assess the efficacy of ketotifen, 1 mg twice daily, in the inhibition of bronchoconstriction induced by isocapnic hyperventilation (IH). There was no significant difference in the degree of bronchoconstriction produced by IH after treatment with ketotifen or placebo.This publication has 16 references indexed in Scilit:
- Controversies in the pathogenesis of exercise-induced asthma.1986
- A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjectsJournal of Allergy and Clinical Immunology, 1984
- Comparison of the Protective Effect of Ketotifen and Disodium Cromoglycate on Exercise‐Induced Asthma in Asthmatic BoysAllergy, 1983
- Antigen Bronchial Challenge and Efficacy after 4 Weeks of Treatment with Ketotifen and Disodium CromoglycateRespiration, 1983
- A comparison of ketotifen with clemastine, ipratropium bromide and sodium cromoglycate in exercise‐induced asthmaClinical and Experimental Allergy, 1982
- Hyperventilation of exercise to induce asthma?Thorax, 1981
- Ketotifen in atopic asthma and exercise-induced asthma.Thorax, 1981
- Exercise-Induced AsthmaNew England Journal of Medicine, 1979
- Ketotifen: a histamine release inhibitor.1977
- The ventilatory capacity of patients with chronic airways obstruction.1969